Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorHelpWear Inc.

About this trial

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.

Eligibility criteria

Qualifiers

At least 22 years of age at time of consent

Clinically indicated for a Holter monitor test

Able to wear the HeartWatch on the left bicep for the study duration

Able to follow the protocol

Disqualifiers

Known allergy to any component of the Holter monitor

Known allergy to any component of the HeartWatch

Inability to wear the HeartWatch on the left arm for the study period due to pre-existing medical condition (3.g., functional AV fistula in left arm, prior carcinoma with lymph node dissection or lymphedema, known blood clot of recurrent blood clots in the left arm, chronic neuropathic pain in left arm, ...)

Dextrocardia

Trial design

Treatments tested in this trial

  • HeartWatch

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators